Joel Greenblatt · Magic Formula : forte rentabilité du capital à un EV/EBIT bas
Is Vertex Pharmaceuticals Incorporated (VRTX) a Joel Greenblatt Stock?
Partial match: either cheap or high-quality, but not both.
55/100
Mitigé
1/5 critères validés
Les critères de Joel Greenblatt, appliqués à VRTX
EBIT/EV yield ≥ 10%
clé4.3%
ROIC ≥ 25%
clé17.7%
EV/EBIT ≤ 12
23.1x
Gross margin ≥ 30%
86.3%
Comment VRTX se classe selon d'autres stratégies
Données financières en direct
Cap. boursière
$127.93B
PER (TTM)
26.2x
ROIC (TTM)
17.74%
Marge brute
86.28%
Autres analyses Joel Greenblatt
Questions fréquentes
What is VRTX's Joel Greenblatt fit score?
VRTX scores 55/100 on our Joel Greenblatt fit engine. Partial match: either cheap or high-quality, but not both.
Does Joel Greenblatt actually own VRTX?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends VRTX.
How often is this score updated?
VRTX's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Outil éducatif, pas un conseil en investissement. Les scores sont calculés à partir de données financières publiques selon les critères publiés de chaque stratégie d'investissement. Nous ne prétendons pas que Joel Greenblatt possède ou recommande VRTX personnellement.
